Radiopharm Theranostics Limited (AU:RAD) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Radiopharm Theranostics Limited has announced a new application for the quotation of over 37 million securities under the code RADOA, which are options expiring in August 2026. This application, detailed in Appendix 2A, aligns with the ASX Listing Rules and marks a significant new development for the company’s financial instruments.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.